Latest Insider Transactions at Vericel Corp (VCEL)
This section provides a real-time view of insider transactions for Vericel Corp (VCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vericel Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vericel Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2023
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+12.88%
|
-
|
|
Apr 27
2023
|
Paul K Wotton |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+7.56%
|
-
|
|
Apr 27
2023
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+25.0%
|
-
|
|
Apr 27
2023
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+14.4%
|
-
|
|
Apr 27
2023
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+6.5%
|
-
|
|
Apr 27
2023
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+23.01%
|
-
|
|
Apr 27
2023
|
Lisa Wright |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+32.57%
|
-
|
|
Apr 25
2023
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+16.67%
|
$30,000
$10.6 P/Share
|
|
Mar 01
2023
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.94%
|
$30,000
$10.6 P/Share
|
|
Feb 19
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-10.05%
|
$54,172
$29.82 P/Share
|
|
Feb 19
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+17.07%
|
-
|
|
Feb 19
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
752
-1.41%
|
$21,808
$29.82 P/Share
|
|
Feb 19
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+3.19%
|
-
|
|
Feb 19
2023
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-11.87%
|
$24,128
$29.82 P/Share
|
|
Feb 19
2023
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+19.98%
|
-
|
|
Feb 19
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,938
+4.73%
|
-
|
|
Feb 19
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,143
-2.3%
|
$120,147
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-14.81%
|
$4,698
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
419
+27.69%
|
-
|
|
Feb 18
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-8.28%
|
$38,628
$29.82 P/Share
|
|
Feb 18
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+14.88%
|
-
|
|
Feb 18
2023
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-7.21%
|
$30,885
$29.82 P/Share
|
|
Feb 18
2023
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,754
+15.72%
|
-
|
|
Feb 18
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-2.11%
|
$32,132
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+4.24%
|
-
|
|
Feb 18
2023
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,155
-18.01%
|
$33,495
$29.82 P/Share
|
|
Feb 18
2023
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+26.61%
|
-
|
|
Feb 18
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+6.22%
|
-
|
|
Feb 18
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,423
-3.07%
|
$157,267
$29.82 P/Share
|
|
Feb 11
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-12.99%
|
$57,507
$29.3 P/Share
|
|
Feb 11
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+18.65%
|
-
|
|
Feb 11
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
840
-1.65%
|
$24,360
$29.3 P/Share
|
|
Feb 11
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+3.09%
|
-
|
|
Feb 11
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-2.09%
|
$101,935
$29.3 P/Share
|
|
Feb 11
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.27%
|
-
|
|
Feb 06
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.62%
|
$9,300
$30.6 P/Share
|
|
Feb 06
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+1.29%
|
-
|
|
Feb 06
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,253
-1.98%
|
$97,590
$30.6 P/Share
|
|
Feb 06
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+4.06%
|
-
|
|
Feb 06
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-7.75%
|
$29,640
$30.6 P/Share
|
|
Feb 06
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+12.82%
|
-
|
|
Feb 02
2023
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
330
-32.84%
|
$10,230
$31.0 P/Share
|
|
Jan 10
2023
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
39,938
-20.27%
|
$1,078,326
$27.13 P/Share
|
|
Jan 10
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,938
+16.86%
|
$998,450
$25.8 P/Share
|
|
Oct 14
2022
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
331
-27.45%
|
$8,275
$25.47 P/Share
|
|
Sep 30
2022
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-22.94%
|
$6,348
$23.2 P/Share
|
|
Sep 30
2022
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
937
+43.79%
|
-
|
|
Jun 01
2022
|
Lisa Wright |
BUY
Exercise of conversion of derivative security
|
Direct |
433
+13.46%
|
-
|
|
Apr 29
2022
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
900
-14.75%
|
$27,000
$30.94 P/Share
|
|
Apr 27
2022
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+16.83%
|
-
|